🔎 Trials Near Me

Utama › Mesotelioma › Colorado

Kajian klinikal Mesotelioma di Colorado

8 kajian untuk Mesotelioma sedang mencari peserta di lokasi di Colorado.

Bandar di Colorado

Teks kajian rasmi (Bahasa Inggeris)

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  • SCRI at HCA HealthONE, Denver
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07705334

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

  • Sarah Cannon Research Institute at HealthONE, Denver
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06566079

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • Grand Valley Oncology, Grand Junction
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05732831

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  • Rocky Mountain Cancer Centers, LLP - Oncology, Lone Tree
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05245500

Integrated Cancer Repository for Cancer Research

  • Advent Health, Greenwood Village
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699

CT-95 in Advanced Cancers Associated With Mesothelin Expression

  • Context Investigational Site, Denver
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jun 2026 · NCT06756035

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

  • University of Colorado Cancer Center, Aurora
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Apr 2026 · NCT06362369

A Study of NX-1607 in Adults With Advanced Malignancies

  • University of Colorado School of Medicine, Aurora
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2025 · NCT05107674

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.